{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:38:12Z","timestamp":1781887092542,"version":"3.54.5"},"reference-count":54,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Purpose: To evaluate the utility and comparative effectiveness of three five-point qualitative scoring systems for assessing response on PET-CT and MRI imaging individually and in combination, following curative-intent chemoradiotherapy (CRT) in locally advanced cervical cancer (LACC). Their performance in the prediction of subsequent patient outcomes was also assessed; Methods: Ninety-seven patients with histologically confirmed LACC treated with CRT using standard institutional protocols at a single centre who underwent PET-CT and MRI at staging and post treatment were identified retrospectively from an institutional database. The post-CRT imaging studies were independently reviewed, and response assessed using five-point scoring tools for T2WI, DWI, and FDG PET-CT. Patient characteristics, staging, treatment, and follow-up details including progression-free survival (PFS) and overall survival (OS) outcomes were collected. To compare diagnostic performance metrics, a two-proportion z-test was employed. A Kaplan\u2013Meier analysis (Mantel\u2013Cox log-rank) was performed. Results: The T2WI (p &lt; 0.00001, p &lt; 0.00001) and DWI response scores (p &lt; 0.00001, p = 0.0002) had higher specificity and accuracy than the PET-CT. The T2WI score had the highest positive predictive value (PPV), while the negative predictive value (NPV) was consistent across modalities. The combined MR scores maintained high NPV, PPV, specificity, and sensitivity, and the PET\/MR consensus scores showed superior diagnostic accuracy and specificity compared to the PET-CT score alone (p = 0.02926, p = 0.0083). The Kaplan\u2013Meier analysis revealed significant differences in the PFS based on the T2WI (p &lt; 0.001), DWI (p &lt; 0.001), combined MR (p = 0.003), and PET-CT\/MR consensus scores (p &lt; 0.001) and in the OS for the T2WI (p &lt; 0.001), DWI (p &lt; 0.001), and combined MR scores (p = 0.031) between responders and non-responders. Conclusion: Post-CRT response assessment using qualitative MR scoring and\/or consensus PET-CT and MRI scoring was a better predictor of outcome compared to PET-CT assessment alone. This requires validation in a larger prospective study but offers the potential to help stratify patient follow-up in the future.<\/jats:p>","DOI":"10.3390\/cancers16030476","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T07:22:32Z","timestamp":1705994552000},"page":"476","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prediction of Patient Outcomes in Locally Advanced Cervical Carcinoma Following Chemoradiotherapy\u2014Comparative Effectiveness of Magnetic Resonance Imaging and 2-Deoxy-2-[18F]fluoro-D-glucose Imaging"],"prefix":"10.3390","volume":"16","author":[{"given":"Simran Singh","family":"Dhesi","sequence":"first","affiliation":[{"name":"Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2681-9922","authenticated-orcid":false,"given":"Russell","family":"Frood","sequence":"additional","affiliation":[{"name":"Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK"},{"name":"Leeds Institute of Health Research, Faculty of Medicine & Health, University of Leeds, Leeds LS9 7TF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Swift","sequence":"additional","affiliation":[{"name":"Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Leeds Cancer Centre, Leeds LS9 7TF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Muzumdar","sequence":"additional","affiliation":[{"name":"Department of Radiology, Chelsea & Westminster Hospital, 369 Fulham Rd., London SW10 9NH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehvish","family":"Jamal","sequence":"additional","affiliation":[{"name":"Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4243-032X","authenticated-orcid":false,"given":"Andrew","family":"Scarsbrook","sequence":"additional","affiliation":[{"name":"Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK"},{"name":"Leeds Institute of Health Research, Faculty of Medicine & Health, University of Leeds, Leeds LS9 7TF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","unstructured":"Ries, L.A.G., Melbert, D., Krapcho, M., Stinchcomb, D.G., Howlader, N., Horner, M.J., Mariotto, A., Miller, B.A., Feuer, E.J., and Altekruse, S.F. (2008). SEER Cancer Statistics Review, 1975\u20132005, National Cancer Institute."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e14600","DOI":"10.1097\/MD.0000000000014600","article-title":"Prevalence of cervical cancer and pre-cancerous lesions among unscreened Women in Kumasi, Ghana","volume":"98","author":"Donkoh","year":"2019","journal-title":"Medicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Perrone, A.M., Dondi, G., Coe, M., Ferioli, M., Telo, S., Galuppi, A., De Crescenzo, E., Tesei, M., Castellucci, P., and Nanni, C. (2020). Predictive role of MRI and 18F FDG PET response to concurrent chemoradiation in T2b cervical cancer on clinical outcome: A retrospective single center study. Cancers, 12.","DOI":"10.3390\/cancers12030659"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3322\/canjclin.51.2.92","article-title":"Cervical cancer: Prevention, diagnosis, and therapeutics","volume":"51","author":"Janicek","year":"2001","journal-title":"CA Cancer J. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00428-023-03552-3","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer\u2013Update 2023","volume":"482","author":"Cibula","year":"2023","journal-title":"Virchows Archiv"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"iv72","DOI":"10.1093\/annonc\/mdx220","article-title":"Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Marth","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/cam4.722","article-title":"Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients","volume":"5","author":"Fagotti","year":"2016","journal-title":"Cancer Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.ejso.2016.05.011","article-title":"Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survival","volume":"42","author":"Fanfani","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","article-title":"Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01","volume":"22","author":"Eifel","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.radonc.2011.07.012","article-title":"Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer","volume":"100","author":"Georg","year":"2011","journal-title":"Radiother. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00330-018-5510-3","article-title":"Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: A multicentre study","volume":"29","author":"Thomeer","year":"2019","journal-title":"Eur. Radiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2214\/AJR.19.21604","article-title":"Value of intratumoral metabolic heterogeneity and quantitative 18F-FDG PET\/CT parameters in predicting prognosis for patients with cervical cancer","volume":"214","author":"Pinho","year":"2020","journal-title":"Am. J. Roentgenol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s13244-017-0567-0","article-title":"The value of advanced MRI techniques in the assessment of cervical cancer: A review","volume":"8","author":"Dappa","year":"2017","journal-title":"Insights Imaging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00259-015-3194-3","article-title":"Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer","volume":"43","author":"Nilsson","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/cncr.23817","article-title":"Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2\/II cervical carcinoma with chemoradiation therapy: Correlation of radiologic findings with surgicopathologic results","volume":"113","author":"Vincens","year":"2008","journal-title":"Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/ijgc-2018-000108","article-title":"Detection of distant metastatic disease by positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) at initial staging of cervical carcinoma","volume":"29","author":"Lin","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/MNM.0000000000000851","article-title":"18F-FDG PET\/CT in the evaluation of cancer cervix: Where do we stand today?","volume":"39","author":"Palaniswamy","year":"2018","journal-title":"Nucl. Med. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00259-016-3537-8","article-title":"Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy","volume":"44","author":"Scarsbrook","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1016\/j.ejrad.2012.02.015","article-title":"Predictive role of post-treatment [18F] FDG PET\/CT in patients with uterine cervical cancer","volume":"81","author":"Chung","year":"2012","journal-title":"Eur. J. Radiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s13139-013-0248-y","article-title":"The role of 18 F-FDG PET\/CT in assessing therapy response in cervix cancer after concurrent chemoradiation therapy","volume":"48","author":"Choi","year":"2014","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ygyno.2018.04.080","article-title":"Utilization of preoperative PET-CT and pelvic MRI reduces multimodality therapy in the care of women with early-stage cervical carcinoma","volume":"149","author":"Diver","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1148\/rg.232025705","article-title":"Clinical role of FDG PET in evaluation of cancer patients","volume":"23","author":"Kostakoglu","year":"2003","journal-title":"Radiographics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s002590050597","article-title":"Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine","volume":"26","author":"Cook","year":"1999","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00259-017-3884-0","article-title":"Comparison of positron emission tomography\/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy","volume":"45","author":"Su","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijrobp.2018.01.092","article-title":"Use of functional magnetic resonance imaging in cervical cancer patients with incomplete response on positron emission tomography\/computed tomography after image-based high-dose-rate brachytherapy","volume":"102","author":"Kalash","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1007\/s00330-022-08648-z","article-title":"Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy","volume":"32","author":"Adusumilli","year":"2022","journal-title":"Eur. Radiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13562","DOI":"10.1038\/s41598-022-17942-1","article-title":"The quality-adjusted life-years in the oncological patients\u2019 health-related quality of life","volume":"12","author":"Kucnerowicz","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_32","unstructured":"ICRU International Commission on Radiation Units and Measurements (1985). Dose and Volume Specifications for Reporting Intracavitary Therapy in Gynecology, ICRU International Commission on Radiation Units and Measurements. ICRU Report 38."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2214\/AJR.07.2211","article-title":"Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer","volume":"189","author":"Haider","year":"2007","journal-title":"Am. J. Roentgenol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1007\/s00330-015-4156-7","article-title":"Prediction of disease progression following concurrent chemoradiotherapy for uterine cervical cancer: Value of post-treatment diffusion-weighted imaging","volume":"26","author":"Park","year":"2016","journal-title":"Eur. Radiol."},{"key":"ref_35","unstructured":"Sprinthall, R.C. (2011). Basic Statistical Analysis, Allyn and Bacon."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.328.7447.1073","article-title":"The logrank test","volume":"328","author":"Bland","year":"2004","journal-title":"BMJ"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2307\/1402659","article-title":"Analysis of survival data under the proportional hazards model","volume":"43","author":"Breslow","year":"1975","journal-title":"Int. Stat. Rev.\/Rev. Int. Stat."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1148\/rg.326125519","article-title":"The revised FIGO staging system for uterine malignancies: Implications for MR imaging","volume":"32","author":"Freeman","year":"2012","journal-title":"Radiographics"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2003.01.102","article-title":"Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer","volume":"21","author":"Yen","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00259-018-4077-1","article-title":"Prognostic value of posttreatment 18 F-FDG PET\/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: An analysis of intensity-and volume-based PET parameters","volume":"45","author":"Lima","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/IGC.0000000000000612","article-title":"Quality of life in women after pelvic exenteration for gynecological malignancies: A multicentric study","volume":"28","author":"Dessole","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1002\/cncr.25991","article-title":"Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer","volume":"117","author":"Siva","year":"2011","journal-title":"Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2012.08.006","article-title":"Complete metabolic response after definitive radiation therapy for cervical cancer: Patterns and factors predicting for recurrence","volume":"127","author":"Beriwal","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1001\/jama.298.19.2289","article-title":"Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma","volume":"298","author":"Schwarz","year":"2007","journal-title":"JAMA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/IGC.0b013e3182a80aec","article-title":"Survival after curative pelvic exenteration for primary or recurrent cervical cancer: A retrospective multicentric study of 167 patients","volume":"24","author":"Chiantera","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1148\/rg.234035001","article-title":"Uterine cervical carcinoma after therapy: CT and MR imaging findings","volume":"23","author":"Jeong","year":"2003","journal-title":"Radiographics"},{"key":"ref_47","first-page":"227","article-title":"F18-FDG-PET\/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma","volume":"63","author":"Cetina","year":"2011","journal-title":"Rev. Investig. Cl\u00edn."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/IGC.0b013e3182428925","article-title":"Value of magnetic resonance and 18FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: A prospective pathology-matched study","volume":"22","author":"Vandecasteele","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1007\/s00330-019-06265-x","article-title":"Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [18 F]-fluorodeoxyglucose positron emission tomography\/computed tomography","volume":"29","author":"Shen","year":"2019","journal-title":"Eur. Radiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1177\/0284185115617346","article-title":"Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery","volume":"57","author":"Gui","year":"2016","journal-title":"Acta Radiol."},{"key":"ref_51","first-page":"67","article-title":"The value of magnetic resonance imaging in the assessment of chemoradiotherapy of cancer of cervix uteri","volume":"3","year":"2019","journal-title":"Radiol. Update"},{"key":"ref_52","first-page":"26","article-title":"Effectiveness of neoadjuvant chemotherapy followed by radical surgery in young patients with locally advanced cervical cancer","volume":"44","author":"Gong","year":"2023","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3810\/pgm.2008.11.1928","article-title":"HPV and cervical cancer: Updates on an established relationship","volume":"120","author":"Subramanya","year":"2008","journal-title":"Postgrad. Med."},{"key":"ref_54","unstructured":"Jamal, M., Cooper, R., Dhesi, S., Scarsbrook, A., and Frood, R. (March, January 28). Prediction of outcome post-chemoradiotherapy in locally advanced cervical carcinoma (LACC) using radiomic feature analysis of FDG PET-CT imaging. Proceedings of the European Congress of Radiology (ECR), Vienna, Austria."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/3\/476\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:47:42Z","timestamp":1760104062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/3\/476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["cancers16030476"],"URL":"https:\/\/doi.org\/10.3390\/cancers16030476","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]}}}